Elicio Therapeutics (ELTX) Misses Q3 EPS by 60c

Elicio Therapeutics (NASDAQ: ELTX) reported Q3 EPS of ($0.60).

For earnings history and earnings-related data on Elicio Therapeutics (ELTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'